120.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ILMN Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$120.67
Aprire:
$119.15
Volume 24 ore:
1.63M
Relative Volume:
0.98
Capitalizzazione di mercato:
$4.96B
Reddito:
$4.28B
Utile/perdita netta:
$1.26B
Rapporto P/E:
15.21
EPS:
7.8957
Flusso di cassa netto:
$943.00M
1 W Prestazione:
-1.35%
1M Prestazione:
+25.79%
6M Prestazione:
+43.60%
1 anno Prestazione:
-11.08%
Illumina Inc Stock (ILMN) Company Profile
Nome
Illumina Inc
Settore
Industria
Telefono
(858) 202-4500
Indirizzo
5200 ILLUMINA WAY, SAN DIEGO, CA
Confronta ILMN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
ILMN
Illumina Inc
|
120.08 | 18.44B | 4.28B | 1.26B | 943.00M | 7.8957 |
|
TMO
Thermo Fisher Scientific Inc
|
567.16 | 217.43B | 43.74B | 6.58B | 6.11B | 17.31 |
|
A
Agilent Technologies Inc
|
144.52 | 41.62B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
DHR
Danaher Corp
|
220.44 | 156.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
MTD
Mettler Toledo International Inc
|
1,388.96 | 28.66B | 3.87B | 829.75M | 847.84M | 39.48 |
|
WAT
Waters Corp
|
377.98 | 22.59B | 2.91B | 622.64M | 620.14M | 10.48 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Downgrade | Daiwa Securities | Outperform → Neutral |
| 2025-07-11 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| 2025-03-04 | Reiterato | Citigroup | Neutral |
| 2025-02-28 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-02-10 | Downgrade | Barclays | Equal Weight → Underweight |
| 2025-02-07 | Downgrade | TD Cowen | Buy → Hold |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-11-12 | Ripresa | Morgan Stanley | Equal-Weight |
| 2024-10-17 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2024-08-28 | Aggiornamento | Argus | Hold → Buy |
| 2024-08-16 | Aggiornamento | Daiwa Securities | Neutral → Buy |
| 2024-08-14 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2024-08-14 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-07-10 | Aggiornamento | Citigroup | Neutral → Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | HSBC Securities | Buy → Hold |
| 2024-01-04 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Aggiornamento | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Aggiornamento | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-14 | Iniziato | Stephens | Overweight |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Aggiornamento | Citigroup | Sell → Neutral |
| 2023-11-10 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Iniziato | Bernstein | Underperform |
| 2023-07-05 | Ripresa | JP Morgan | Neutral |
| 2023-01-25 | Downgrade | Argus | Buy → Hold |
| 2023-01-05 | Iniziato | Scotiabank | Sector Perform |
| 2022-12-12 | Downgrade | Citigroup | Neutral → Sell |
| 2022-12-07 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-10-04 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Neutral |
| 2022-07-13 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Aggiornamento | Stifel | Hold → Buy |
| 2022-01-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Ripresa | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Ripresa | Piper Sandler | Overweight |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Iniziato | Barclays | Underweight |
| 2020-12-22 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-10-13 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-09-30 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Downgrade | Stifel | Buy → Hold |
| 2020-09-22 | Downgrade | UBS | Buy → Neutral |
| 2020-09-21 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-09-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Downgrade | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Downgrade | Guggenheim | Buy → Neutral |
| 2020-04-24 | Downgrade | Citigroup | Buy → Neutral |
| 2020-04-21 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Iniziato | Wells Fargo | Underweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2020-01-02 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Iniziato | Stifel | Buy |
| 2019-10-25 | Iniziato | Guggenheim | Buy |
Mostra tutto
Illumina Inc Borsa (ILMN) Ultime notizie
Strategies to average down on Illumina Inc.Quarterly Trade Report & Expert Approved Momentum Ideas - newser.com
Why analysts maintain buy rating on Illumina Inc. (ILU) stockWeekly Stock Recap & Daily Oversold Bounce Ideas - newser.com
Is Illumina Inc. (ILU) stock inflation resilientWeekly Market Outlook & Fast Exit and Entry Trade Guides - newser.com
Will Illumina Inc. (ILU) stock keep high P E multiplesLayoff News & Verified Momentum Stock Alerts - newser.com
Published on: 2025-11-16 14:04:19 - newser.com
Why Illumina Inc. stock is considered a top pickInsider Selling & Intraday High Probability Alerts - newser.com
Why The Narrative Around Illumina Is Shifting After Recent Analyst Upgrades and Sector Changes - Yahoo Finance
Is Illumina Inc. forming a bottoming baseWeekly Stock Report & Low Volatility Stock Recommendations - newser.com
Why Illumina Inc. (ILU) stock benefits from AI revolution2025 Earnings Surprises & Proven Capital Preservation Methods - newser.com
What moving averages say about Illumina Inc.July 2025 Final Week & Low Drawdown Trading Strategies - newser.com
Is Illumina Inc. stock a buy in volatile marketsIPO Watch & Free Fast Gain Swing Trade Alerts - newser.com
Technical analysis overview for Illumina Inc. stockMarket Growth Review & Low Drawdown Investment Ideas - newser.com
Analyzing Illumina Inc. with risk reward ratio charts2025 Fundamental Recap & Expert Curated Trade Setup Alerts - newser.com
Illumina Inc Stock Analysis and ForecastVolatility Trading Techniques & Fast Profit Stock Ideas - earlytimes.in
Real time pattern detection on Illumina Inc. stockQuarterly Profit Review & Proven Capital Preservation Tips - newser.com
Is Illumina Inc. (ILU) stock a buy on weaknessPortfolio Performance Report & Accurate Buy Signal Alerts - newser.com
Will Illumina Inc. stock benefit from automationJuly 2025 Rallies & Low Drawdown Trading Strategies - newser.com
Illumina’s Market Dominance Faces New Test As Roche Plans 2026 Sequencer Launch - Citeline News & Insights
Published on: 2025-11-13 22:27:47 - newser.com
Key facts: Illumina to Issue $500M Notes; Officer Files to Sell Shares - TradingView
Illumina: Will Its Latest China Partnerships Unlock Its Next Billion-Dollar Market? - Smartkarma
Combining machine learning predictions for Illumina Inc.Recession Risk & Weekly Momentum Stock Picks - newser.com
What Nebraska knows about better precision oncology - Illumina
Momentum divergence signals in Illumina Inc. chartPortfolio Return Report & Growth-Oriented Investment Plans - newser.com
Will Illumina Inc. (ILU) stock draw ESG focused fundsQuarterly Performance Summary & Precise Swing Trade Alerts - newser.com
Illumina, Inc. (ILU.DE) stock price, news, quote and history - Yahoo Finance UK
Illumina study shows whole-genome sequencing solves missing heritability By Investing.com - Investing.com Nigeria
Published on: 2025-11-12 23:20:26 - newser.com
Illumina Announces $500M Notes Issuance Agreement - TipRanks
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study - PR Newswire
Illumina Inc files for offering of $500 million 4.750% notes due 2030 - MarketScreener
Illumina Inc Azioni (ILMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):